The Food and Drug Administration (FDA) has published guidance titled “Radio Frequency Wireless Technology in Medical Devices; Guidance for Industry and Food and Drug Administration Staff.” The document seeks to minimize the risks associated with medical devices that use the technology in an environment where many sources of radio frequency (RF) energy are found and RF wireless emissions from one product could potentially affect the function of another. The guidance addresses safety and effectiveness issues such as (i) the selection of wireless technology, (ii) the quality of service, (iii) coexistence, (iv) security, and (v) electromagnetic compatibility. It also provides recommendations for information to be included in FDA premarket submissions for these devices. See Federal Register, August 14, 2013.